According to Bloomberg News, Vinay Prasad, who oversees gene therapies at the FDA, said the plans will be published in early November. He foresees the approach sparking curiosity for the next wave of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback